The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling | Zendy

Noah Kolb | Zendy; A. Gordon Smith | Zendy; J. Robinson Singleton | Zendy; Susan L. Beck | Zendy; Gregory J. Stoddard | Zendy; Summer Brown | Zendy; Kathi Mooney | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling

Author(s) -

Noah Kolb,

A. Gordon Smith,

J. Robinson Singleton,

Susan L. Beck,

Gregory J. Stoddard,

Summer Brown,

Kathi Mooney

Publication year - 2016

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2016.0383

Subject(s) - medicine , taxane , chemotherapy induced peripheral neuropathy , chemotherapy , peripheral neuropathy , oncology , breast cancer , cancer , endocrinology , diabetes mellitus

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of neurotoxic chemotherapy resulting in pain, sensory loss, and decreased quality of life. Few studies have prospectively examined the relationship between sensory neuropathy symptoms, falls, and fall-related injuries for patients receiving neurotoxic chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research